Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

由 Sheppard, John, Bergmann, Mark, Schechter, Barry A, Luchs, Jodi, Ogundele, Abayomi, Karpecki, Paul
發表在 Clin Ophthalmol (2021)

The Valued Life Activities Scale (VLAs): linguistic validation, cultural adaptation and psychometric testing in people with rheumatic and musculoskeletal diseases in the UK

由 Prior, Y., Tennant, A., Tyson, S., Hammond, A.
發表在 BMC Musculoskelet Disord (2020)

Vandetanib and indwelling pleural catheter for non-small cell lung cancer with recurrent malignant pleural effusion

由 Massarelli, Erminia, Onn, Amir, Marom, Edith M., Alden, Christine M., Liu, Diane D., Tran, Hai T., Mino, Barbara, Wistuba, Ignacio I., Faiz, Saadia A., Bashoura, Lara, Eapen, George A., Morice, Rodolfo C., Jack Lee, J., Hong, Waun K., Herbst, Roy S., Jimenez, Carlos A.
出版 2014

Continuous oral contraceptives versus long-term pituitary desensitization prior to IVF/ICSI in moderate to severe endometriosis: study protocol of a non-inferiority randomized controlled trial

由 van der Houwen, L E E, Lier, M C I, Schreurs, A M F, van Wely, M, Hompes, P G A, Cantineau, A E P, Schats, R, Lambalk, C B, Mijatovic, V
發表在 Hum Reprod Open (2019)

Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO‐INSIGHTFUL study

由 Hong, C‐H., Papp, K.A., Lophaven, K.W., Skallerup, P., Philipp, S.
發表在 J Eur Acad Dermatol Venereol (2017)

Growth performance and nutrient digestibility of growing and finishing pigs fed multienzyme-supplemented low-energy and -amino acid diets

由 Jerez-Bogota, Kevin, Sánchez, Cristian, Ibagon, Jimena, Jlali, Maamer, Cozannet, Pierre, Preynat, Aurélie, Woyengo, Tofuko A
發表在 Transl Anim Sci (2020)

Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies

由 Kunos, Charles A., Brindle, James, Waggoner, Steven, Zanotti, Kristine, Resnick, Kimberly, Fusco, Nancy, Adams, Ramon, Debernardo, Robert
出版 2012

SOUTHWEST ONCOLOGY GROUP PHASE II TRIAL (S0341) OF ERLOTINIB (OSI-774) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AND A PERFORMANCE STATUS OF 2

由 Hesketh, Paul J., Chansky, Kari, Wozniak, Antoinette J., Hirsch, Fred R., Spreafico, Anna, Moon, James, Mack, Philip C., Marchello, Benjamin T., Franklin, Wilbur A., Crowley, John J., Gandara, David R.
出版 2008

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.

由 Pyrhönen, S., Valavaara, R., Modig, H., Pawlicki, M., Pienkowski, T., Gundersen, S., Bauer, J., Westman, G., Lundgren, S., Blanco, G., Mella, O., Nilsson, I., Hietanen, T., Hindy, I., Vuorinen, J., Hajba, A.
出版 1997

The impact of “super-dosing” phytase in pig diets on growth performance during the nursery and grow-out periods()

由 Holloway, Cassie L, Boyd, R Dean, Koehler, Dean, Gould, Stacie A, Li, Qingyun, Patience, John F
發表在 Transl Anim Sci (2018)

A Phase III Randomized, Double Blind, Placebo-Controlled Study of Pilocarpine for Vaginal Dryness: NCCTG study N04CA

由 Loprinzi, Charles L., Balcueva, Ernie P., Liu, Heshan, Sloan, Jeff A., Kottschade, Lisa A., Stella, Philip J., Carlson, Mark D., Moore, Dennis F., Zon, Robin T., Levitt, Ralph, Jaslowski, Anthony J.
出版 2011

Thymidylate Synthase (TYMS) Enhancer Region Genotype-Directed Phase II Trial of Oral Capecitabine for 2nd Line Treatment of Advanced Pancreatic Cancer

由 Weekes, Colin D., Nallapareddy, Sujatha, Rudek, Michelle A., Norris-Kirby, Alexis, Laheru, Daniel, Jimeno, Antonio, Donehower, Ross C., Murphy, Kathleen M., Hidalgo, Manuel, Baker, Sharyn D., Messersmith, Wells A.
出版 2010

Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial

由 Verschuur, Arnauld C., Bajčiová, Viera, Mascarenhas, Leo, Khosravan, Reza, Lin, Xun, Ingrosso, Antonella, Janeway, Katherine A.
發表在 Cancer Chemother Pharmacol (2019)

Use of the Hedgehog signaling pathway inhibitor in the treatment of recurrent locally advanced and metastatic basal cell skin cancer

由 Z. A.-G. Radzhabova, M. A. Kotov, Z. S. Bekyasheva, M. A. Radzhabova, E. V. Levchenko
出版 2020-02-01

A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

由 Robison, Nathan J, Campigotto, Federico, Chi, Susan N, Manley, Peter E, Turner, Christopher D, Zimmerman, Mary Ann, Chordas, Christine A, Werger, Annette M, Allen, Jeffrey C, Goldman, Stewart, Rubin, Joshua B, Isakoff, Michael S, Pan, Wilbur J, Khatib, Ziad A, Comito, Melanie A, Bendel, Anne E, Pietrantonio, Jay B, Kondrat, Laura, Hubbs, Shannon M, Neuberg, Donna S, Kieran, Mark W
發表在 Pediatr Blood Cancer (2014)

SUN-125 Phase Ib Study of Dual Therapy with an Aromatase Inhibitor Exemestane and Carboplatin-Based...

由 Young, Patricia A, Marquez-Garban, Diana C, Goodglick, Lee, Noor, Zorawar S, Moatamed, Neda, Elashoff, David, Grogan, Tristan, Romero, Tahmineh, Sasano, Hironobu, Saito, Ryoko, Rausch, Rebecca, Hamilton, Nalo, Dubinett, Steven M, Garon, Edward, Pietras, Richard J
發表在 J Endocr Soc (2020)

A phase II trial of abiraterone combined with dutasteride for men with metastatic castration-resistant prostate cancer

由 McKay, Rana R., Werner, Lillian, Mostaghel, Elahe A., Lis, Rosina, Voznesensky, Olga, Zhang, Zhenwei, Marck, Brett T., Matsumoto, Alvin M., Domachevsky, Liran, Zukotynski, Katherine A., Bhasin, Manoj, Bubley, Glenn J., Montgomery, Bruce, Kantoff, Philip W., Balk, Steven P., Taplin, Mary-Ellen
發表在 Clin Cancer Res (2016)

A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory...

由 Moreno-González, G., Mussetti, A., Albasanz-Puig, A., Salvador, I., Sureda, A., Gudiol, C., Salazar, R., Marin, M., Garcia, M., Navarro, V., de la Haba Vaca, I., Coma, E., Sanz-Linares, G., Dura, X., Fontanals, S., Serrano, G., Cruz, C., Mañez, R.
發表在 Trials (2021)

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

由 Kwak, Eunice L., Bang, Yung-Jue, Camidge, D. Ross, Shaw, Alice T., Solomon, Benjamin, Maki, Robert G., Ou, Sai-Hong I., Dezube, Bruce J., Jänne, Pasi A., Costa, Daniel B., Varella-Garcia, Marileila, Kim, Woo-Ho, Lynch, Thomas J., Fidias, Panos, Stubbs, Hannah, Engelman, Jeffrey A., Sequist, Lecia V., Tan, WeiWei, Gandhi, Leena, Mino-Kenudson, Mari, Wei, Greg C., Shreeve, S. Martin, Ratain, Mark J., Settleman, Jeffrey, Christensen, James G., Haber, Daniel A., Wilner, Keith, Salgia, Ravi, Shapiro, Geoffrey I., Clark, Jeffrey W., Iafrate, A. John
出版 2010

A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non...

由 Dy, Grace K., Hillman, Shauna L., Rowland, Kendrith M., Molina, Julian R., Steen, Preston D., Wender, Donald B., Nair, Suresh, Mandrekar, Sumithra, Schild, Steven E., Adjei, Alex A.
發表在 Cancer (2010)